Brintellix is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Takeda Pharmaceuticals America, Inc.. The primary component is Vortioxetine Hydrobromide.
Product ID | 64764-560_cc70d6dd-e54b-483d-83f5-762a6cce455a |
NDC | 64764-560 |
Product Type | Human Prescription Drug |
Proprietary Name | Brintellix |
Generic Name | Vortioxetine |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2013-10-02 |
Marketing Category | NDA / NDA |
Application Number | NDA204447 |
Labeler Name | Takeda Pharmaceuticals America, Inc. |
Substance Name | VORTIOXETINE HYDROBROMIDE |
Active Ingredient Strength | 10 mg/1 |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 2013-10-02 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA204447 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2013-10-02 |
Marketing End Date | 2019-08-15 |
Marketing Category | NDA |
Application Number | NDA204447 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2013-10-02 |
Marketing End Date | 2019-08-15 |
Marketing Category | NDA |
Application Number | NDA204447 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2013-10-02 |
Marketing End Date | 2019-08-15 |
Marketing Category | NDA |
Application Number | NDA204447 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2013-10-02 |
Marketing End Date | 2019-08-15 |
Marketing Category | NDA |
Application Number | NDA204447 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2013-10-02 |
Marketing End Date | 2019-08-15 |
Ingredient | Strength |
---|---|
VORTIOXETINE HYDROBROMIDE | 10 mg/1 |
SPL SET ID: | 4b0700c9-b417-4c3a-b36f-de461e125bd3 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
64764-550 | Brintellix | vortioxetine |
64764-560 | Brintellix | vortioxetine |
64764-570 | Brintellix | vortioxetine |
64764-580 | Brintellix | vortioxetine |
55154-0256 | Trintellix | vortioxetine |
55154-0257 | Trintellix | vortioxetine |
64764-720 | Trintellix | vortioxetine |
64764-730 | Trintellix | vortioxetine |
64764-750 | Trintellix | vortioxetine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
BRINTELLIX 88844656 not registered Live/Pending |
H. Lundbeck A/S 2020-03-23 |
BRINTELLIX 86463470 4873005 Live/Registered |
H. Lundbeck A/S 2014-11-24 |
BRINTELLIX 86463444 4873004 Live/Registered |
H. Lundbeck A/S 2014-11-24 |
BRINTELLIX 79389431 not registered Live/Pending |
H. Lundbeck A/S 2023-11-23 |
BRINTELLIX 79114307 4420245 Live/Registered |
H. Lundbeck A/S 2012-03-26 |